Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia
about
The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancerRegulation of TGF-β signal transduction by mono- and deubiquitylation of SmadsMyeloid malignancies: mutations, models and managementTif1γ regulates the TGF-β1 receptor and promotes physiological aging of hematopoietic stem cellsLentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitroDynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation.Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.Tumour suppressor TRIM33 targets nuclear β-catenin degradationTIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemiaAutoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis.TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcomeTiF1-gamma plays an essential role in murine hematopoiesis and regulates transcriptional elongation of erythroid genesMutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.Chronic myelomonocytic leukemia: Forefront of the field in 2015.Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblastsLoss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanismsTripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein.Macrophage production and activation are dependent on TRIM33.Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders.Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations.An evolutionary perspective on chronic myelomonocytic leukemia.Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practice.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.Turning the tide in myelodysplastic/myeloproliferative neoplasms.TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathway.Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.Adenovirus E4orf3 targets transcriptional intermediary factor 1γ for proteasome-dependent degradation during infection.Trim33 is essential for macrophage and neutrophil mobilization to developmental or inflammatory cues.The TIF1α-related TRIM cofactors couple chromatin modifications to transcriptional regulation, signaling and tumor suppression.Hematology Testing in Mice.Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.TRIM proteins in blood cancers.Anti-transcription intermediary factor 1γ antibody titer correlates with clinical symptoms in a patient with recurrent dermatomyositis associated with ovarian cancer.[TIF1γ: a tumor suppressor gene in chronic myelomonocytic leukemia].The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features.Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.
P2860
Q21128760-4F97B581-5407-4359-A778-FB29369638B5Q26827667-4D5D8152-FDBF-4CED-91CA-516E0A124450Q27000577-DC347DB1-22EB-4B28-A4B6-B80E867FD02DQ28243485-F47C423F-87E3-4299-B256-6414403C23FCQ33598835-6F08EA05-2AD6-4DEE-90F0-E424D65C6E67Q34213815-C34E70DD-AE97-4866-8015-045922BC2A55Q34218656-2E8741AF-81AE-497F-83AD-AB06DF6A7CE6Q34791339-BEC63BD4-2218-44D5-9939-DDBAA74A84E5Q35043217-7F0AF337-29E7-418B-8D88-6E297DD0F329Q35651935-0873F50B-6E03-4608-9F9F-F118132FD795Q35836896-43E79C56-37D7-405A-A5A9-621B4A97276DQ36245820-499E3730-434E-4826-969A-1598C66B16BCQ36414270-263A7A07-E571-40F1-9EFC-A29D725E6972Q36520899-F2B0C11D-6648-4A37-A7BC-D12E9E9EC42CQ36627526-8DD23AB6-D918-467B-AAF8-612EA1C9B9D6Q36876853-58973716-7091-4931-9A36-C8B2D817E103Q36936451-41E152D2-A80F-4F25-9E68-D25A7D1344A7Q37161750-5ED4A029-4C0C-4261-80B5-7E5EC0594B50Q37289213-10B92206-984E-4E3F-BF27-3B64046E9861Q37706314-B953594E-7F26-43D9-8AE8-632836FA6295Q37956169-3C041416-F726-4AB2-AE24-CF7F60EBDC46Q37993420-26A75BCF-6C0F-4D33-AB9A-B923C62D0AF6Q38096235-9A1F32E3-C2FE-44AE-8480-C2304F33EE7DQ38241774-A56FBEB7-8D15-4820-9931-1DEDB72E92BDQ38596370-839E4AFC-23C8-4CCD-A276-533CEB2CF97EQ38712988-177CF1BE-1A99-404A-B29E-8124D51D20D1Q38722523-62FFDB3A-E7AD-484E-BCEC-BF7FF0FA3FD7Q38876622-6E54615C-3521-465E-8976-8C2090819AF2Q38982192-4F8B6A79-4127-47E9-BB78-234664D0377EQ39421013-84C26621-2F5B-4637-AF5F-138258BFBC2AQ40127502-336C9748-2F06-4937-BE43-64ACEE46DDC6Q40645850-6657CB1E-59DF-47F8-BBAD-8101DC7F7FEBQ40841674-C6EF07A1-9107-4E9C-B359-319A0EE1A1F5Q41485219-9860A631-56E0-4F81-9D5A-90AD0C80B5D6Q47433060-C44A4BA2-E4B7-4531-AA6F-C953CF493143Q48227990-B2056CDF-9E07-4422-83A8-C2A0061C72FAQ53282390-D8F1FA91-ECAE-4BE4-BD5A-1761980D3A88Q53347165-EA926C46-DA15-4BE2-9563-5FABA4A6652BQ53830978-A622C2F0-919C-43E8-89F8-1EF00E8CD8C1Q55371625-F34B97D4-DBFC-4A0B-BC07-0E6B8091CC40
P2860
Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@ast
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@en
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@nl
type
label
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@ast
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@en
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@nl
prefLabel
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@ast
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@en
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@nl
P2093
P2860
P356
P1476
Transcription intermediary fac ...... hronic myelomonocytic leukemia
@en
P2093
Amandine Bataille
Anne Largeot
Arlette Hammann
Brice Lagrange
Jean-Noël Bastie
Jérôme Paggetti
Kai-Ping Yan
Laurent Delva
Laurent Martin
Nathalie Droin
P2860
P304
P356
10.1172/JCI45213
P407
P577
2011-06-01T00:00:00Z